HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- AI tools for earlier pancreatic cancer diagnosis may yield ‘increasingly better outcomes’ Jennifer R. Southall
-
- Another year of resolutions: Don’t kid yourself Nicholas J. Petrelli, MD, FACS
- A little cultural humility can go a long way toward achieving equity in cancer survivorship Jennifer R. Southall
- Artificial intelligence may help predict cardiotoxicity in renal cell carcinoma Mark Leiser
- Dexamethasone fails to relieve shortness of breath among patients with cancer Jennifer R. Southall
- Early transplant referral may improve cell therapy access, outcomes in blood cancers Jennifer R. Southall
- Early treatment of COVID-19 crucial for patients with cancer Jennifer Byrne
- End-stage renal disease after renal cell carcinoma linked to shorter survival Mark Leiser
- Exercise linked to better mental, physical health among those with kidney cancer Mark Leiser
-
- Immunotherapy a ‘significant improvement’ for treatment of multiple myeloma Drew Amorosi
- Lung cancer screening leads to more stage I, less stage IV disease incidence Jennifer R. Southall
- Lung cancer screening rates in US ‘simply unacceptable’ Matthew Shinkle
- Many children, adolescents with sickle cell anemia still do not receive recommended care Jennifer Byrne
- Most women who take anticoagulants for blood clots experience abnormal menstrual bleeding Drew Amorosi
- Neurofeedback may be effective for addressing ‘chemo brain’ Jennifer Byrne; Stephen Sideroff, PhD
- New regimens show promise for management of advanced cervical cancer Devin McLaughlin
- Practice-changing treatment advances continue in early-stage triple-negative breast cancer Jennifer R. Southall
-
- Reduced aspirin use linked to lower bleeding risk among patients on warfarin Jennifer R. Southall
- Research aims to spare children from painful adverse effects of chemotherapy Jennifer Byrne; Hana Starobova, PhD
- Sequencing of surgery, immunotherapy impacts outcomes in melanoma Jennifer R. Southall
- Shift to targeted therapies continues in relapsed/refractory indolent non-Hodgkin lymphoma Devin McLaughlin
- Spaceflight may be linked to somatic mutations, increased risk for cancer, heart disease Jennifer Byrne; Agnieszka Brojakowska, BA; David Goukassian, MD, PhD
- Trial to investigate impact of genomic tumor board on physician, patient outcomes Jennifer Byrne; Jens Rueter, MD; Meghna S. Trivedi, MD, MS
- Trials for advanced renal cell carcinoma often use restrictive eligibility criteria Mark Leiser
- ASTRO honors two Gold Medal recipients
-
- Cancer institute names chief of blood disorders
- Cedars-Sinai Cancer names director of breast oncology Matthew Shinkle
- Oncologist posthumously receives humanitarian award named in his honor Mark Leiser
- Capivasertib regimen extends PFS in advanced breast cancer Matthew Shinkle
- Nivolumab prolongs RFS in resected stage II melanoma
- Onivyde regimen prolongs OS vs. chemotherapy in metastatic pancreatic ductal adenocarcinoma